Schrodinger, Inc. - Common Stock (SDGR)

Schrodinger Inc is a biotechnology company that leverages advanced computational technology and artificial intelligence to drive drug discovery and development

By combining physics-based modeling and machine learning, the company aims to streamline the identification of potential therapeutic candidates, optimize their properties, and predict their efficacy and safety profiles. Schrodinger’s platform is designed to accelerate the research process, enabling pharmaceutical companies and academic institutions to innovate in the fields of drug design and materials science, ultimately contributing to the improvement of human health through the development of new medicines.